Publications by authors named "Keith Dillman"

Claim this Profile
D
Development of a Series of Pyrrolopyridone MAT2A Inhibitors.
Stephen J Atkinson, Sharan K Bagal, Argyrides Argyrou, Sean Askin, Tony Cheung, Keith Dillman

J Med Chem· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Series of 5-Azaquinazolines as Orally Efficacious IRAK4 Inhibitors Targeting MyD88 Mutant Diffuse Large B Cell Lymphoma.
Sébastien L Degorce, Rana Anjum, Andrew Bloecher, Rodrigo J Carbajo, Keith S Dillman

J Med Chem· November 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimization of permeability in a series of pyrrolotriazine inhibitors of IRAK4.
Sébastien L Degorce, Rana Anjum, Keith S Dillman, Lisa Drew, Sam D Groombridge

Bioorg Med Chem· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery and Optimization of Pyrrolopyrimidine Inhibitors of Interleukin-1 Receptor Associated Kinase 4 (IRAK4) for the Treatment of Mutant MYD88 Diffuse Large B-Cell Lymphoma.
James S Scott, Sébastien L Degorce, Rana Anjum, Janet Culshaw, Robert D M Davies, Keith S Dillman

J Med Chem· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Next-generation sequencing identifies a novel ELAVL1-TYK2 fusion gene in MOLM-16, an AML cell line highly sensitive to the PIM kinase inhibitor AZD1208.
Adriana E Tron, Erika K Keeton, Minwei Ye, Matias Casas-Selves, Huawei Chen, Keith S Dillman

Leuk Lymphoma· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards the next generation of dual Bcl-2/Bcl-xL inhibitors.
Jeffrey G Varnes, Thomas Gero, Shan Huang, R Bruce Diebold, Claude Ogoe, Keith Dillman

Bioorg Med Chem Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AZD1208, a potent and selective pan-Pim kinase inhibitor, demonstrates efficacy in preclinical models of acute myeloid leukemia.
Erika K Keeton, Kristen McEachern, Keith S Dillman, Sangeetha Palakurthi, Yichen Cao

Blood· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure guided development of novel thymidine mimetics targeting Pseudomonas aeruginosa thymidylate kinase: from hit to lead generation.
Jun Yong Choi, Mark S Plummer, Jeremy Starr, Charlene R Desbonnet, Holly Soutter, Keith Dillman

J Med Chem· January 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-content screening for compounds that affect mtDNA-encoded protein levels in eukaryotic cells.
Sashi Nadanaciva, Keith Dillman, David F Gebhard, Alka Shrikhande, Yvonne Will

J Biomol Screen· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mechanism for the allosteric regulation of phosphodiesterase 2A deduced from the X-ray structure of a near full-length construct.
Jayvardhan Pandit, Michael D Forman, Kimberly F Fennell, Keith S Dillman, Frank S Menniti

Proc Natl Acad Sci U S A· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structural basis for the catalytic mechanism of human phosphodiesterase 9.
Shenping Liu, Mahmoud N Mansour, Keith S Dillman, Jose R Perez, Dennis E Danley

Proc Natl Acad Sci U S A· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis